Plasma growth differentiation factor 15: a novel tool to detect early changes of hereditary transthyretin amyloidosis

AIMS: Hereditary transthyretin (ATTRv) amyloidosis is the most frequent and representative form of autosomal dominant hereditary systemic amyloidosis. Disease‐modifying treatments of the disease are more effective during the early stages, and we require biomarkers to detect early pathological change...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :ESC Heart Fail
Главные авторы: Okada, Masamitsu, Misumi, Yohei, Masuda, Teruaki, Takashio, Seiji, Tasaki, Masayoshi, Matsushita, Hiroaki, Ueda, Akihiko, Inoue, Yasuteru, Nomura, Toshiya, Nakajima, Makoto, Yamashita, Taro, Shinriki, Satoru, Matsui, Hirotaka, Tsujita, Kenichi, Ando, Yukio, Ueda, Mitsuharu
Формат: Artigo
Язык:Inglês
Опубликовано: John Wiley and Sons Inc. 2020
Предметы:
Original Research Articles
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC8006664/
https://ncbi.nlm.nih.gov/pubmed/33381924
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.13176
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы